Related Experiment Videos
Anti-platelet aggregation constituents from Formosan Toddalia asiatica
1Graduate Institute of Pharmaceutical Sciences, Kaohsiung Medical College, Taiwan, R.O.C.
Phytochemistry
|August 28, 1998
Summary
Researchers identified 30 compounds from Formosan Toddalia asiatica, including two new ones. Seven isolated compounds demonstrated significant anti-platelet aggregation activity in vitro, highlighting potential therapeutic applications.
Area of Science:
- Phytochemistry
- Pharmacology
Background:
- Formosan Toddalia asiatica is a plant source of bioactive natural products.
- Natural products are crucial for drug discovery and development.
Purpose of the Study:
- To isolate and characterize compounds from the wood of Formosan Toddalia asiatica.
- To evaluate the isolated compounds for anti-platelet aggregation activity.
Main Methods:
- Phytochemical investigation involving isolation and structure elucidation of compounds using spectroscopic data and chemical evidence.
- Bioassay-guided fractionation to identify active compounds.
- In vitro anti-platelet aggregation assays.
Main Results:
- Thirty compounds were isolated, including coumarins, alkaloids, a benzoquinone, and an amine.
- Two new compounds, (+/-)-toddanin and (-)-isocoreximine, were identified.
- Cyclohexylamine was isolated from a natural source for the first time.
- Seven compounds exhibited strong in vitro anti-platelet aggregation activity.
Conclusions:
- The wood of Formosan Toddalia asiatica is a rich source of diverse chemical compounds.
- Several isolated compounds possess significant potential for anti-platelet aggregation therapy.
- Further research into these compounds could lead to novel anti-thrombotic agents.